[
  {
    "uuid": "94af6ea6fd73b5ca14ee42ee4f1cb5055a41b766",
    "url": "https://en.tempo.co/read/1814416/morowali-smelter-blast-pt-imip-workers-urge-company-to-improve-ohs-system",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Najla Nur Fauziyah",
    "published": "2023-12-28T13:06:00Z",
    "title": "Morowali Smelter Blast; PT IMIP Workers Urge Company to Improve OHS System - News En.tempo.co",
    "text": "Morowali Smelter Blast; PT IMIP Workers Urge Company to Improve OHS System Translator Editor 28 December 2023 08:06 WIB TEMPO.CO, Jakarta - The head of the labor union of IMIP Hendri said that the compensation given to the victims of the [smelter](https://www.tempo.co/search?waktu=&kanal=&subkanal=&domain=2&q=smelter) fire is not an adequate remedy for the situation. \"Don't let the compensation for the victims lead IMIP to neglect its main obligation to improve the occupational health and safety (OHS or locally K3) system to protect workers,\" Hendri said in a written statement received by Tempo on Wednesday, Dec. 27. Workers' safety must be the number one priority, Hendri said. \"A repeat of this tragedy must not occur just because of IMIP's desire for production,\" he added. It was previously reported that the incident happened on Sunday of a smelter furnace owned by PT Indonesia Tsingshan Stainless Steel (ITSS) in Morowali that killed 18 workers. PT IMIP then delivered Rp600 million to compensate for the death of its workers, including school tuition for two of the worker's children. Meanwhile, the Media Relations Head of PT IMIP Dedy Kurniawan said non-fatality victims are to be given compensation in each case. Hendri said that compensation was indeed one of the workers' demands. He also hopes that those injured in the incident will be guaranteed financial aid for treatment. \"Additionally, workers must be compensated and their wages paid and they could resume working [at PT IMIP] post-recovery,\" he said. However, workers also have several other demands, such as periodic revitalization, improvement of health facilities, provision of ambulances at IMIP, and quality OHS officers, as well as erasure of the ferroalloy department. \"We also demand the policy that allows inter-department lending of workers to be canceled and a commemoration of the incident every 24th of December,\" he concluded. RIRI RAHAYU Editor's Choice: [Morowali Smelter Fire: Worker's Safety More Important Than Investor's Interest, Says Observer](https://en.tempo.co/read/1813736/morowali-smelter-fire-workers-safety-more-important-than-investors-interest-says-observer) [Click here](https://news.google.com/publications/CAAqBggKMMnVJTCC7gU?hl=en-ID&gl=ID&ceid=ID:en) to get the latest news updates from Tempo on Google News",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "negative",
    "categories": [
      "Health",
      "Labor",
      "Disaster and Accident"
    ],
    "external_links": [
      "https://news.google.com/publications/CAAqBggKMMnVJTCC7gU?hl=en-ID&gl=ID&ceid=ID:en)",
      "https://www.news.google.com/publications/CAAqBggKMMnVJTCC7gU?hl=en-ID&gl=ID&ceid=ID:en)",
      "https://news.google.com/publications/CAAqBggKMMnVJTCC7gU"
    ],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "hendri",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "pt imip workers urge company",
          "sentiment": "negative"
        },
        {
          "name": "pt indonesia tsingshan stainless steel",
          "sentiment": "none"
        },
        {
          "name": "imip",
          "sentiment": "none"
        }
      ],
      "locations": [
        {
          "name": "jakarta",
          "sentiment": "none"
        },
        {
          "name": "morowali",
          "sentiment": "none"
        }
      ]
    },
    "rating": null,
    "crawled": "2023-12-29T00:11:03.208+02:00",
    "updated": "2023-12-29T00:11:03.208+02:00"
  },
  {
    "uuid": "17faf26f695ede10c4ba91c3a68135e704d28136",
    "url": "https://brooklyneagle.com/articles/2025/04/09/flatbush-students-face-debt-at-liu",
    "ord_in_thread": 0,
    "author": "Brooklyn Eagle Staff",
    "published": "2025-04-09T21:13:00Z",
    "title": "Flatbush students face debt at LIU",
    "text": "Flatbush students face debt at LIU\nFLATBUSH ‚Äî THE ROC NATION SCHOOL of Music at Long Island University, a performing arts program backed by rap mogul Jay-Z, allegedly made students offers of graduating ‚Äúwithout debt‚Äù ‚Äì but LIU says many now owe thousands, frustrated alumni told Gothamist.\nLaunched in 2021, the program offered elite facilities, celebrity instructors and full-tuition scholarships. Students showed Gothamist letters claiming they would be able to graduate ‚Äúwithout debt.‚Äù In at least one case, a student alleged that LIU‚Äôs president, Kimberly Kline, reached out to her via text after graduating high school to make the debt-free offer.\nStudents in the first-year class, who entered in 2021, say they were then blindsided by fees for housing, insurance and other expenses, currently set at $22,000 a year, and are struggling to repay these costs, with some having dropped out over the burden. Gothamist found that in 2023, the university changed language on its website from ‚Äúdebt-free‚Äù to ‚Äútuition-free,‚Äù which the school now argues is a distinction its students should have understood.\nStudents also said the promised facilities did not exist, with some freshmen having to construct a DIY recording studio in an empty classroom, and that the celebrity lecturers promised in advertisements never materialized.\n‚ú∞‚ú∞‚ú∞",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "negative",
    "categories": [
      "Education",
      "Social Issue",
      "Crime, Law and Justice"
    ],
    "topics": [
      "Education->college and university",
      "Education->students",
      "Social Issue->social problem",
      "Social Issue->social services"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [
      "https://gothamist.com/news/a-brooklyn-school-backed-by-jay-z-said-students-could-graduate-debt-free-now-theyre-buried-in-it",
      "https://www.gothamist.com/news/a-brooklyn-school-backed-by-jay-z-said-students-could-graduate-debt-free-now-theyre-buried-in-it"
    ],
    "entities": {
      "persons": [
        {
          "name": "Kimberly Kline",
          "sentiment": "none"
        },
        {
          "name": "Gothamist",
          "sentiment": "none"
        },
        {
          "name": "Jay-Z",
          "sentiment": "none"
        }
      ],
      "locations": [],
      "organizations": [
        {
          "name": "LIU Flatbush",
          "sentiment": "negative",
          "tickers": []
        }
      ]
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "bias": null,
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-04-10T00:22:57.807+03:00",
    "updated": "2025-04-10T00:22:57.807+03:00"
  },
  {
    "uuid": "80a6ed69dffdbcbdc5802a65ad8e43d349a0ab80",
    "url": "https://www.stocktitan.net/news/IVBIY/seven-oral-presentations-innovent-to-present-breakthrough-clinical-kdsjeqwn80pw.html",
    "ord_in_thread": 0,
    "author": "StockTitan",
    "published": "2025-04-23T23:00:00Z",
    "title": "Seven Oral Presentations: Innovent to Present Breakthrough Clinical Data of IBI363ÔºàPD-1/IL-2Œ±-biasÔºâand Other Novel Drug Candidates at the 2025 ASCO Annual Meeting | IVBIY Stock News",
    "text": "Seven Oral Presentations: Innovent to Present Breakthrough Clinical Data of IBI363ÔºàPD-1/IL-2Œ±-biasÔºâand Other Novel Drug Candidates at the 2025 ASCO Annual Meeting\nInnovent Biologics will present breakthrough clinical data at the 2025 ASCO Annual Meeting from May 30 to June 3 in Chicago. The company will showcase seven oral presentations, highlighting significant developments in their oncology pipeline.\nKey presentations include data for IBI363 (PD-1/IL-2Œ±-bias) in three indications: melanoma, colorectal cancer, and non-small cell lung cancer. Additionally, IBI343 (CLDN18.2 ADC) Phase 1b data in pancreatic cancer will receive an oral presentation, building on its previous success at ESMO Asia.\nThe presentations will also feature results from various clinical trials, including the ORIENT-21 Phase 3 study of sintilimab plus ICE in Hodgkin lymphoma, the SPRING-01 trial in rectal cancer, and the EP-STAR trial in nasopharyngeal carcinoma. Multiple poster presentations will showcase additional data from the company's diverse oncology portfolio.\nInnovent Biologics presenter√† dati clinici rivoluzionari al 2025 ASCO Annual Meeting, che si terr√† dal 30 maggio al 3 giugno a Chicago. L'azienda proporr√† sette presentazioni orali, mettendo in luce importanti sviluppi nel suo pipeline oncologico.\nTra le presentazioni principali figurano i dati relativi a IBI363 (PD-1/IL-2Œ±-bias) in tre indicazioni: melanoma, tumore del colon-retto e carcinoma polmonare non a piccole cellule. Inoltre, i dati di Fase 1b di IBI343 (CLDN18.2 ADC) nel tumore pancreatico saranno presentati oralmente, consolidando il successo ottenuto in precedenza a ESMO Asia.\nLe presentazioni includeranno anche risultati provenienti da diversi studi clinici, tra cui lo studio di Fase 3 ORIENT-21 su sintilimab pi√π ICE nel linfoma di Hodgkin, la sperimentazione SPRING-01 nel carcinoma rettale e la sperimentazione EP-STAR nel carcinoma nasofaringeo. Numerose presentazioni poster mostreranno ulteriori dati dal variegato portafoglio oncologico dell‚Äôazienda.\nInnovent Biologics presentar√° datos cl√≠nicos innovadores en el 2025 ASCO Annual Meeting, que se celebrar√° del 30 de mayo al 3 de junio en Chicago. La compa√±√≠a ofrecer√° siete presentaciones orales, destacando avances significativos en su cartera oncol√≥gica.\nLas presentaciones clave incluyen datos de IBI363 (PD-1/IL-2Œ±-bias) en tres indicaciones: melanoma, c√°ncer colorrectal y c√°ncer de pulm√≥n no microc√≠tico. Adem√°s, los datos de fase 1b de IBI343 (CLDN18.2 ADC) en c√°ncer de p√°ncreas ser√°n presentados oralmente, reforzando su √©xito previo en ESMO Asia.\nLas presentaciones tambi√©n mostrar√°n resultados de varios ensayos cl√≠nicos, incluyendo el estudio de fase 3 ORIENT-21 de sintilimab m√°s ICE en linfoma de Hodgkin, el ensayo SPRING-01 en c√°ncer rectal y el ensayo EP-STAR en carcinoma nasofar√≠ngeo. Varias presentaciones en formato p√≥ster exhibir√°n datos adicionales del diverso portafolio oncol√≥gico de la empresa.\nInnovent BiologicsÍ∞Ä 5Ïõî 30ÏùºÎ∂ÄÌÑ∞ 6Ïõî 3ÏùºÍπåÏßÄ ÏãúÏπ¥Í≥†ÏóêÏÑú Ïó¥Î¶¨Îäî 2025 ASCO Ïó∞Î°ÄÌöåÏùòÏóêÏÑú ÌöçÍ∏∞Ï†ÅÏù∏ ÏûÑÏÉÅ Îç∞Ïù¥ÌÑ∞Î•º Î∞úÌëúÌï©ÎãàÎã§. ÌöåÏÇ¨Îäî 7Í±¥Ïùò Íµ¨Îëê Î∞úÌëúÎ•º ÌÜµÌï¥ Ï¢ÖÏñëÌïô ÌååÏù¥ÌîÑÎùºÏù∏Ïùò Ï§ëÏöîÌïú Î∞úÏ†Ñ ÏÇ¨Ìï≠ÏùÑ ÏÜåÍ∞úÌï† ÏòàÏ†ïÏûÖÎãàÎã§.\nÏ£ºÏöî Î∞úÌëú ÎÇ¥Ïö©ÏóêÎäî ÏÑ∏ Í∞ÄÏßÄ Ï†ÅÏùëÏ¶ùÏù∏ ÌùëÏÉâÏ¢Ö, ÎåÄÏû•Ïïî, ÎπÑÏÜåÏÑ∏Ìè¨ÌèêÏïîÏóê ÎåÄÌïú IBI363(PD-1/IL-2Œ±-bias) Îç∞Ïù¥ÌÑ∞Í∞Ä Ìè¨Ìï®Îê©ÎãàÎã§. ÎòêÌïú IBI343(CLDN18.2 ADC)Ïùò Ï∑åÏû•Ïïî 1bÏÉÅ Îç∞Ïù¥ÌÑ∞ÎèÑ Íµ¨Îëê Î∞úÌëúÎ°ú ÏÑ†Î≥¥Ïù¥Î©∞, Ïù¥Îäî Ïù¥Ï†Ñ ESMO AsiaÏóêÏÑúÏùò ÏÑ±Í≥µÏùÑ Í∏∞Î∞òÏúºÎ°ú Ìï©ÎãàÎã§.\nÎ∞úÌëúÏóêÎäî Ìò∏ÏßÄÌÇ® Î¶ºÌîÑÏ¢ÖÏóêÏÑú sintilimabÍ≥º ICE Î≥ëÏö©Ïùò ORIENT-21 3ÏÉÅ Ïó∞Íµ¨, ÏßÅÏû•Ïïî SPRING-01 ÏûÑÏÉÅÏãúÌóò, ÎπÑÏù∏ÎëêÏïî EP-STAR ÏûÑÏÉÅÏãúÌóò Í≤∞Í≥ºÎèÑ Ìè¨Ìï®Îê©ÎãàÎã§. Îã§ÏàòÏùò Ìè¨Ïä§ÌÑ∞ Î∞úÌëúÎ•º ÌÜµÌï¥ ÌöåÏÇ¨Ïùò Îã§ÏñëÌïú Ï¢ÖÏñëÌïô Ìè¨Ìä∏Ìè¥Î¶¨Ïò§Ïóê ÎåÄÌïú Ï∂îÍ∞Ä Îç∞Ïù¥ÌÑ∞ÎèÑ Í≥µÍ∞úÎê† ÏòàÏ†ïÏûÖÎãàÎã§.\nInnovent Biologics pr√©sentera des donn√©es cliniques r√©volutionnaires lors du ASCO Annual Meeting 2025, qui se tiendra du 30 mai au 3 juin √† Chicago. La soci√©t√© proposera sept pr√©sentations orales, mettant en avant des avanc√©es majeures dans leur pipeline oncologique.\nLes pr√©sentations cl√©s incluent des donn√©es sur IBI363 (PD-1/IL-2Œ±-bias) dans trois indications : m√©lanome, cancer colorectal et cancer du poumon non √† petites cellules. De plus, les donn√©es de phase 1b de IBI343 (CLDN18.2 ADC) dans le cancer du pancr√©as feront l‚Äôobjet d‚Äôune pr√©sentation orale, s‚Äôappuyant sur le succ√®s pr√©c√©dent √† ESMO Asia.\nLes pr√©sentations comprendront √©galement les r√©sultats de plusieurs essais cliniques, notamment l‚Äô√©tude de phase 3 ORIENT-21 du sintilimab associ√© √† ICE dans le lymphome de Hodgkin, l‚Äôessai SPRING-01 dans le cancer du rectum, et l‚Äôessai EP-STAR dans le carcinome nasopharyng√©. De nombreuses pr√©sentations sous forme de posters mettront en lumi√®re des donn√©es suppl√©mentaires du portefeuille oncologique diversifi√© de l‚Äôentreprise.\nInnovent Biologics wird bahnbrechende klinische Daten auf dem 2025 ASCO Annual Meeting vom 30. Mai bis 3. Juni in Chicago pr√§sentieren. Das Unternehmen wird sieben m√ºndliche Pr√§sentationen vorstellen, die bedeutende Fortschritte in ihrer Onkologie-Pipeline hervorheben.\nZu den wichtigsten Pr√§sentationen geh√∂ren Daten zu IBI363 (PD-1/IL-2Œ±-bias) in drei Indikationen: Melanom, kolorektales Karzinom und nicht-kleinzelliges Lungenkarzinom. Zudem werden Phase-1b-Daten von IBI343 (CLDN18.2 ADC) beim Bauchspeicheldr√ºsenkrebs in einer m√ºndlichen Pr√§sentation vorgestellt, die auf dem bisherigen Erfolg bei ESMO Asia aufbauen.\nDie Pr√§sentationen umfassen au√üerdem Ergebnisse verschiedener klinischer Studien, darunter die Phase-3-Studie ORIENT-21 zu Sintilimab plus ICE bei Hodgkin-Lymphom, die SPRING-01-Studie bei Rektumkarzinom und die EP-STAR-Studie bei Nasopharynxkarzinom. Zahlreiche Posterpr√§sentationen zeigen zus√§tzliche Daten aus dem vielf√§ltigen onkologischen Portfolio des Unternehmens.\n- Multiple breakthrough clinical data presentations at major oncology conference\n- Three indications for IBI363 accepted for oral presentations\n- Successful Phase 1b data for IBI343 in pancreatic cancer\n- Strong presence in both IO and ADC platforms\n- None.\nDr. Hui Zhou, Senior Vice President of Innovent, stated: \"We are delighted to announce that at 2025 ASCO Annual Meeting, the first wave of three indications under development for IBI363‚Äîmelanoma, colorectal cancer(CRC), and non-small cell lung cancer (NSCLC)‚Äîhave all been accepted for oral presentations, highlighting the significant attention garnered by the next-generation bispecific antibodies, in particular PD-1-based immunotherapy. Additionally, following its oral presentation at ESMO Asia last December, the Phase 1b data of IBI343 in pancreatic cancer has once again secured an oral presentation at ASCO, further solidifying its potential in this challenging therapeutic area. The maturing PoC data for these innovative candidates has strengthened our confidence in advancing them into pivotal-stage development, with the goal of unlocking their clinical value for global unmet clinical needs. As one of the few biopharmaceutical companies with both the advanced technology platforms and robust pipeline in \"IO+ADC\" areas, Innovent will continue to make breakthroughs in the field of cancer treatment, and is committed to providing physicians and patients with more innovative, effective and safe treatment options.\"\nDetails on the abstracts are listed below:\nOral Presentation\n1. Presentation Title: Efficacy and safety results of a first-in-class PD-1/IL-2Œ±-bias bispecific antibody fusion protein, IBI363, in patients with immunotherapy-treated, advanced acral and mucosal melanoma\nAbstract Number: 2502\nSession Type: Oral Abstract\nSession Title: Developmental Therapeutics-Immunotherapy\nSession Date & Time: 5/31/2025 3:00 PM-6:00 PM CDT\nPresenter: Jun Guo, MD, Beijing Cancer Hospital\n2. Presentation Title: Efficacy and safety of IBI363 monotherapy or in combination with bevacizumab in patients with advanced colorectal cancer\nAbstract Number: 104\nSession Type: Oral Abstract\nSession Title: Clinical Science Symposium‚ÄîTurning \"Cold\" Tumors \"Hot\"\nSession Date & Time: 6/1/2025 9:45 AM-11:15 AM CDT\nPresenter: Zhenyu Lin, MD, Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology\n3. Presentation Title: First-in-class PD-1/IL-2Œ±-bias bispecific antibody, IBI363, in patients with advanced immunotherapy-treated non-small cell lung cancer (NSCLC)\nAbstract Number: 8509\nSession Type: Oral Abstract\nSession Title: Clinical Science Symposium‚ÄîTwo Targets, One Goal: The Potential for Bispecific Antibodies in Thoracic Malignancies\nSession Date & Time: 6/3/2025 9:45 AM-11:15 AM CDT\nPresenter: Jianya Zhou, MD, The First Affiliated Hospital, Zhejiang University School of Medicine\n4. Presentation Title: Claudin18.2 (CLDN18.2) expression and efficacy in pancreatic ductal adenocarcinoma (PDAC): results from a Phase 1 dose expansion cohort evaluating IBI343\nAbstract Number: 4017\nSession Type: Rapid Oral Abstract\nSession Title: Gastrointestinal Cancer‚ÄîGastroesophageal, Pancreatic, and Hepatobiliary\nSession Date & Time: 6/2/2025 11:30 AM-1:00 PM CDT\nPresenter: Xianjun Yu, MD, Fudan University Shanghai Cancer Center\n5. Presentation Title: Sintilimab (anti-PD-1) plus ifosfamide, carboplatin and etoposide (ICE) in second-line classical Hodgkin lymphoma (cHL): Results of a multicenter, randomized, controlled, double-blind Phase 3 study (\nAbstract Number: 7007\nSession Type: Oral Abstract\nSession Title: Hematologic Malignancies‚ÄîLymphoma and Chronic Lymphocytic Leukemia\nSession Date & Time: 5/30/2025 2:45 PM-5:45 PM CDT\nPresenter: Peng Liu,MD, Cancer Hospital, Chinese Academy of Medical Sciences\n6. Presentation Title: Short-course radiotherapy followed by sintilimab and CAPOX as total neoadjuvant treatment in locally advanced rectal cancer: A prospective, randomized controlled trial (SPRING-01)\nAbstract Number: 3519\nSession Type: Rapid Oral Abstract\nSession Title: Gastrointestinal Cancer-Colorectal and Anal\nSession Date & Time: 6/1/2025 11:30 AM-1:00 PM CDT\nPresenterÔºöChangqing Jing, MD, Shandong Provincial Hospital\n7. Presentation Title: Dynamic circulating tumor DNA-driven, risk-adapted systematic therapy in nasopharyngeal carcinoma: The EP-STAR trial\nAbstract Number: 6010\nSession Type: Oral Abstract\nSession Title: Clinical Science Symposium -Biomarker-Driven Adaptive Therapy: New Horizons in Head and Neck Cancer\nSession Date & Time: 6/2/2025 3:00 PM-4:30 PM CDT\nPresenter: Ying Sun, MD, Sun Yat-sen University Cancer Center\nPoster Presentation\n1. Presentation Title: A multicenter, randomized, controlled, open-label, Phase 2 study of the PD-1/IL-2Œ±-bias bispecific antibody fusion protein IBI363 in mucosal and acral melanoma: Trial in Progress\nAbstract Number: TPS9594\nSession Type: Poster\nSession Title: Melanoma/Skin Cancers\nSession Date & Time: 6/1/2025 9:00 AM-12:00 PM CDT\nPresenter: Bin Lian, MD, Peking University Cancer Hospital & Institute\n2. Presentation Title: IBI354, an anti-HER2 antibody-drug conjugate, in patients with locally advanced unresectable or metastatic ovarian cancers: updated results from a Phase 1 trial\nAbstract Number: 5565\nSession Type: Poster\nSession Title: Gynecologic Cancer\nSession Date & Time: 6/1/2025 9:00 AM-12:00 PM CDT\nPresenter: Jin Shu, MD, Chongqing University Cancer Hospital\n3. Presentation Title: IBI354 (anti-HER2 antibody-drug conjugate [ADC]) in patients with HER2-positive breast cancer (BC) and other solid tumors: Updates from a Phase 1 study\nAbstract Number: 1029\nSession Type: Poster\nSession Title: Breast Cancer‚ÄîMetastatic\nSession Date & Time: 6/2/2025 9:00 AM-12:00 PM CDT\nPresenter: Charlotte Rose Lemech, BSc, FRACP, MBBS , Scientia Clinical Research\n4. Presentation Title: Safety and efficacy of the anti-TROP2 antibody-drug conjugate (ADC) IBI130 in patients with advanced triple-negative breast cancer (TNBC) and other solid tumors: Results from the Phase 1 study\nAbstract Number: 1102\nSession Type: Poster\nSession Title: Breast Cancer‚ÄîMetastatic\nSession Date & Time: 6/2/2025 9:00 AM-12:00 PM CDT\nPresenter: Fan Wu, MD, Fujian Cancer Hospital\n5. Presentation Title: A multiregional, randomized, controlled, open-label, Phase 3 study of the anti-claudin18.2 (CLDN18.2) antibody-drug conjugate (ADC) arcotatug tavatecan (IBI343) in gastric or gastroesophageal junction adenocarcinoma (G/GEJA): Trial in Progress\nAbstract Number: TPS4201\nSession Type: Poster\nSession Title: Gastrointestinal Cancer‚ÄîGastroesophageal, Pancreatic, and Hepatobiliary\nSession Date & Time: 5/31/2025 9:00 AM-12:00 PM CDT\nPresenter: Lin Shen, MD, Beijing Cancer Hospital\n6. Presentation Title: Phase 2 trial of transarterial chemoembolization followed by sintilimab (anti-PD-1), oxaliplatin, and S-1 combined with either trastuzumab (HER-2 positive) or apatinib (HER-2 negative) as first-line therapy for gastric cancer with liver metastases.\nAbstract Number: 4050\nSession Type: Poster\nSession Title: Gastrointestinal Cancer-Gastroesophageal, Pancreatic, and Hepatobiliary\nSession Date & Time: 5/31/2025 9:00 AM-12:00 PM CDT\nPresenter: Dan Sha, MD, Shandong Provincial Hospital\n*Abstracts of TYVYT ¬Æ(sintilimab) are from investigator-initiated clinical trials (IIT), except one abstract, #7007.\nAbout Innovent\nInnovent is a leading biopharmaceutical company founded in 2011 with the mission to empower patients worldwide with affordable, high-quality biopharmaceuticals. The company discovers, develops, manufactures and commercializes innovative medicines that target some of the most intractable diseases. Its pioneering therapies treat cancer, cardiovascular and metabolic, autoimmune and eye diseases. Innovent has launched 15 products in the market. It has 3 new drug applications under regulatory review, 4 assets in Phase III or pivotal clinical trials and 15 more molecules in early clinical stage. Innovent partners with over 30 global healthcare companies, including Eli Lilly, Sanofi, Incyte, Adimab, LG Chem and MD Anderson Cancer Center.\nGuided by the motto, \"Start with Integrity, Succeed through Action,\" Innovent maintains the highest standard of industry practices and works collaboratively to advance the biopharmaceutical industry so that first-rate pharmaceutical drugs can become widely accessible. For more information, visit www.innoventbio.com, or follow Innovent on Facebook and LinkedIn.\nStatement:\n(1) Innovent does not recommend the use of any unapproved drug (s)/indication (s).\n(2) Ramucirumab (Cyramza) and Selpercatinib (Retsevmo) and Pirtobrutinib (Jaypirca) were developed by Eli Lilly and Company.\nForward-looking statement\nThis news release may contain certain forward-looking statements that are, by their nature, subject to significant risks and uncertainties. The words \"anticipate\", \"believe\", \"estimate\", \"expect\", \"intend\" and similar expressions, as they relate to Innovent Biologics (\"Innovent\"), are intended to identify certain of such forward-looking statements. The Company does not intend to update these forward-looking statements regularly.\nThese forward-looking statements are based on the existing beliefs, assumptions, expectations, estimates, projections and understandings of the management of the Company with respect to future events at the time these statements are made. These statements are not a guarantee of future developments and are subject to risks, uncertainties and other factors, some of which are beyond the Company's control and are difficult to predict. Consequently, actual results may differ materially from information contained in the forward-looking statements as a result of future changes or developments in our business, the Company's competitive environment and political, economic, legal and social conditions.\nThe Company, the Directors and the employees of the Company assume (a) no obligation to correct or update the forward-looking statements contained in this site; and (b) no liability in the event that any of the forward-looking statements does not materialise or turn out to be incorrect.\nView original content:https://www.prnewswire.com/news-releases/seven-oral-presentations-innovent-to-present-breakthrough-clinical-data-of-ibi363pd-1il-2-biasand-other-novel-drug-candidates-at-the-2025-asco-annual-meeting-302436193.html\nSOURCE Innovent Biologics",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Health",
      "Science and Technology"
    ],
    "topics": [
      "Health->health treatment and procedure",
      "Health->medical profession",
      "Health->cancer",
      "Science and Technology->medical research",
      "Science and Technology->biomedical science",
      "Science and Technology->biotechnology"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [
      "https://www.prnewswire.com/news-releases/seven-oral-presentations-innovent-to-present-breakthrough-clinical-data-of-ibi363pd-1il-2-biasand-other-novel-drug-candidates-at-the-2025-asco-annual-meeting-302436193.html",
      "http://www.innoventbio.com",
      "https://prnewswire.com/news-releases/seven-oral-presentations-innovent-to-present-breakthrough-clinical-data-of-ibi363pd-1il-2-biasand-other-novel-drug-candidates-at-the-2025-asco-annual-meeting-302436193.html",
      "http://innoventbio.com"
    ],
    "entities": {
      "persons": [],
      "locations": [],
      "organizations": [
        {
          "name": "AM",
          "sentiment": "none",
          "tickers": [
            {
              "ticker": "AM",
              "exchange": "NYSE"
            }
          ]
        },
        {
          "name": "(S",
          "sentiment": "none",
          "tickers": [
            {
              "ticker": "S",
              "exchange": "NYSE"
            }
          ]
        }
      ]
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "bias": null,
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-04-24T02:12:40.514+03:00",
    "updated": "2025-04-24T02:12:40.514+03:00"
  },
  {
    "uuid": "7824b6a45937e961de039b2fac4e27e8006dbf04",
    "url": "https://social1.ne10.uol.com.br/webstory/2023/12/15653145-receita-de-lentilha-pro-ano-novo-para-atrair-prosperidade-para-o-ano-de-2024.html",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Gabriella Zilma",
    "published": "2023-12-29T00:00:00Z",
    "title": "Receita de lentilha pro Ano Novo para atrair prosperidade para o ano de 2024",
    "text": "No Brasil e em algumas outras culturas, o costume de comer lentilhas no Ano Novo est√° associado √† cren√ßa de que essas leguminosas trazem prosperidade e fartura. A lentilha √© considerada um alimento que se assemelha a moedas, simbolizando a riqueza e a abund√¢ncia. Muitas pessoas preparam pratos com lentilhas para celebrar a virada do ano. Confira o passo a passo a seguir. üåü Quer explorar mais? üåü Clique abaixo para ir direto √† nossa Home de Not√≠cias! üì∞ ‚ú® Ou passe os stories para mais novidades. Sua escolha, seu conte√∫do! üëÄ üîç IR PARA SOCIAL1 Receita de lentilha pro Ano Novo Ingredientes: 1 e 1/2 x√≠caras de ch√° de lentilha 1 cubo de caldo de carne 1 cebola picada 1 colher de sopa de azeite 2 x√≠caras de ch√° de √°gua 30 g de lingui√ßa calabresa 3 dentes de alho picado salsinha picada e sal a gosto Modo de Preparo: Deixe a lentilha de molho de um dia para o outro. Escorra a lentilha. Reserve. Pique a lingui√ßa em cubinhos ou fatias, como preferir. Em uma panela de press√£o, coloque a lentilha, a √°gua, o caldo de carne e a lingui√ßa picadinha. üåü Quer explorar mais? üåü Clique abaixo para ir direto √† nossa Home de Not√≠cias! üì∞ ‚ú® Ou passe os stories para mais novidades. Sua escolha, seu conte√∫do! üëÄ üîç IR PARA SOCIAL1 Coloque no fogo e espere come√ßar a apitar. Depois disso, deixe cozinhar por aproximadamente 15 minutos em fogo baixo. Assim que estiver cozido, tempere a lentilha com o restante dos ingredientes. Sirva frio. Receita de lentilha refogada f√°cil e saborosa Ler Mais Fonte: Tudo Gostoso. Ler Mais",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "portuguese",
    "sentiment": "positive",
    "categories": [
      "Lifestyle and Leisure",
      "Religion and Belief",
      "Human Interest"
    ],
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "rating": null,
    "crawled": "2023-12-30T02:44:56.015+02:00",
    "updated": "2023-12-30T02:44:56.015+02:00"
  },
  {
    "uuid": "6b6b0f8919eb4a3b86d46c711d7cb281429a90af",
    "url": "https://www.ozarksfirst.com/news/national-news/mother-of-boys-hit-and-killed-by-socialite-rebecca-grossman-dismayed-by-light-sentence",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Travis Schlepp and Sandra Mitchell",
    "published": "2024-06-13T20:11:00Z",
    "title": "Mother of boys hit and killed by socialite Rebecca Grossman dismayed by light sentence",
    "text": "LOS ANGELES ( KTLA ) ‚Äì The mother of two boys hit and killed by California socialite Rebecca Grossman is expressing her disappointment in Grossman‚Äôs recent sentencing.\nGrossman, 60, was found guilty in February of two counts of second-degree murder, two counts of vehicular manslaughter with gross negligence and one count of hit-and-run driving resulting in death in connection with the collision that killed Jacob, 8, and Mark Iskander, 11 , on Sept. 29, 2020.\nThe co-founder of the Grossman Burn Foundation and wife of prominent plastic surgeon Dr. Peter Grossman had written a letter to the judge from jail ahead of her sentencing pleading for mercy.\nOn Monday, Grossman was sentenced to 15 years to life in prison. She could be eligible for parole in as little as nine years.\nRebecca Grossman, left, and her daughter head to Van Nuys Courthouse West Van Nuys on Feb. 14, 2024. (Irfan Khan / Los Angeles Times via Getty Images) Prosecutors had sought the maximum sentence, which was more than twice what she received.\nThe surprising sentence reopened old wounds for the boys‚Äô mother, Nancy Iskander.\n‚ÄúIt was the hardest day of the whole trial,‚Äù Iskander said. ‚ÄúI would compare Monday to September 29, 2020 , almost to the same extent of pain.‚Äù\nIn an interview at the family home Wednesday, Iskander told Nexstar‚Äôs KTLA that the sentence handed down by the judge was not severe enough and did not honor the life of both her boys.\n‚ÄúHe counted them both as one,‚Äù Iskander said. ‚ÄúThey were two, I promise. They were two.‚Äù\nMourners gathered at a makeshift memorial on Sept. 30, 2020, for Jacob and Mark Iskander, who died after being struck by a vehicle driven by Rebecca Grossman in Westlake Village. (KTLA) ‚ÄúAll I can say about that is that I hope nine years is enough time for her heart to change. I‚Äôm not sure,‚Äù Iskander said.\nThrough a four-year legal ordeal, Grossman has never admitted guilt for running down 11-year-old Mark and 8-year-old Jacob.\nStill, through all the trauma and heartbreak, Iskander says she has love for the person who upended her life.\n‚ÄúI serve a God who teaches me to love and I love her, I love her family, I love her kids, she‚Äôs a human being,‚Äù she said.\nKarim Iskander, right, and wife Nancy Iskander, center, arrive for Rebecca Grossman‚Äôs sentencing on Monday, June 10, 2024 in Van Nuys. (Getty Images) Iskander says the woman responsible for the death of her sons has offered to establish a building near her husband‚Äôs burn hospital and name it after them.\nNancy says that is not something she is willing to entertain.\n‚ÄúThat is not something I would accept from her at all,‚Äù Iskander said. ‚ÄúShe does not get to honor their memory. I‚Äôm sorry, that I cannot allow.‚Äù\nInstead, the Iskander family has created their own foundation to honor Jacob and Mark; Nancy hopes it will be a fitting tribute and do some justice in honoring their memory.\n‚ÄúIt goes through my mind every day, are they proud? Are they looking down and proud of me? Or no? It‚Äôs so important, and I can‚Äôt ask them,‚Äù she said.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "negative",
    "categories": [
      "Crime, Law and Justice",
      "Human Interest"
    ],
    "webz_reporter": false,
    "external_links": [
      "https://ktla.com/news/local-news/rebecca-grossman-found-guilty-in-dui-crash-killing-2-boys-in-l-a-county/",
      "https://ktla.com/news/local-news/rebecca-grossman-pens-letter-to-judge-saying-she-is-not-a-murderer-ahead-of-sentencing/",
      "https://www.markandjacobfoundation.org/",
      "https://ktla.com/news/local-news/woman-arrested-in-westlake-village-crash-that-killed-2-boys/",
      "https://ktla.com/news/local-news/mother-of-boys-killed-by-rebecca-grossman-dismayed-by-light-sentence/",
      "https://ktla.com/news/local-news/they-were-like-2-angels-family-friends-officials-id-young-brothers-killed-in-suspected-dui-crash-in-westlake-village/",
      "http://ktla.com/tag/rebecca-grossman",
      "https://ktla.com/news/local-news/they-were-like-2-angels-family-friends-officials-id-young-brothers-killed-in-suspected-dui-crash-in-westlake-village",
      "https://ktla.com/news/local-news/woman-arrested-in-westlake-village-crash-that-killed-2-boys",
      "https://www.ktla.com/news/local-news/they-were-like-2-angels-family-friends-officials-id-young-brothers-killed-in-suspected-dui-crash-in-westlake-village/",
      "https://ktla.com/news/local-news/rebecca-grossman-found-guilty-in-dui-crash-killing-2-boys-in-l-a-county",
      "https://www.ktla.com/news/local-news/woman-arrested-in-westlake-village-crash-that-killed-2-boys/",
      "https://markandjacobfoundation.org/",
      "https://www.markandjacobfoundation.org",
      "https://ktla.com/news/local-news/mother-of-boys-killed-by-rebecca-grossman-dismayed-by-light-sentence",
      "https://www.ktla.com/news/local-news/rebecca-grossman-pens-letter-to-judge-saying-she-is-not-a-murderer-ahead-of-sentencing/",
      "https://www.ktla.com/news/local-news/mother-of-boys-killed-by-rebecca-grossman-dismayed-by-light-sentence/",
      "http://www.ktla.com/tag/rebecca-grossman",
      "https://ktla.com/news/local-news/rebecca-grossman-pens-letter-to-judge-saying-she-is-not-a-murderer-ahead-of-sentencing",
      "https://www.ktla.com/news/local-news/rebecca-grossman-found-guilty-in-dui-crash-killing-2-boys-in-l-a-county/"
    ],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "rebecca grossman",
          "sentiment": "negative"
        },
        {
          "name": "rebecca grossma",
          "sentiment": "negative"
        },
        {
          "name": "peter grossman",
          "sentiment": "none"
        },
        {
          "name": "mark iskander",
          "sentiment": "none"
        },
        {
          "name": "grossman",
          "sentiment": "none"
        },
        {
          "name": "irfan khan",
          "sentiment": "none"
        },
        {
          "name": "nancy iskand",
          "sentiment": "none"
        },
        {
          "name": "jacob",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "ktla",
          "sentiment": "negative"
        },
        {
          "name": "getty images) prosecutors",
          "sentiment": "none"
        },
        {
          "name": "grossman burn foundation",
          "sentiment": "none"
        },
        {
          "name": "los angeles times",
          "sentiment": "none"
        }
      ],
      "locations": [
        {
          "name": "los angeles",
          "sentiment": "none"
        },
        {
          "name": "california",
          "sentiment": "none"
        },
        {
          "name": "van nuys courthouse west van nuys",
          "sentiment": "none"
        }
      ]
    },
    "rating": null,
    "crawled": "2024-06-14T01:04:40.128+03:00",
    "updated": "2024-06-14T01:04:40.128+03:00"
  },
  {
    "uuid": "13e2b638e9f292d46aa6f9462c06c6408cb84797",
    "url": "https://www.lne.es/sociedad/2024/11/01/lucran-tragedia-han-cobrado-5-111120923.html",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Gonzalo S√°nchez y Marga V√°zquez",
    "published": "2024-11-01T12:37:00Z",
    "title": "DANA EN VALENCIA | Los que se lucran con la tragedia: \"Me han cobrado 5 euros por un botell√≠n de agua de medio litro\"",
    "text": "Las tragedias sacan lo mejor y lo peor de la gente. Una riada de personas se dirige este viernes, d√≠a festivo de Todos los Santos, a las pedan√≠as y localidades del sur de Valencia para ayudar de manera desinteresada a los m√°s afectados por los destrozos de la DANA, que tres d√≠as despu√©s sigue contando v√≠ctimas mortales. Ayudan sin esperar nada a cambio. El otro lado de la moneda son aquellos que se han dedicado al pillaje y el saqueo y a los que han visto en la desgracia una oportunidad para hacer negocio con el bien m√°s preciado en estos momentos: el agua potable. En localidades como Calicanto, Picanya, Aldaia o Alfafar algunos comerciantes han inflado sus precios en pleno estallido de acuciante necesidad. Es el caso de las urbanizaciones situadas en Calicanto, donde sus vecinos est√°n aislados y sin ning√∫n tipo de suministro de agua, luz ni gas. Los m√°s afortunados est√°n cocinando con el carb√≥n que ten√≠an para las barbacoas y ase√°ndose como pueden con el agua de las piscinas. Fr√≠a, por supuesto, por no tienen c√≥mo calentarla. Y para beber... nada. Conseguir agua potable se est√° volviendo una aut√©ntica odisea, incluso fuera de las zonas afectadas por la DANA; dentro, es casi misi√≥n imposible. Ya no s√≥lo porque hay pocas existencias, sino porque no est√°n a la altura de cualquier bolsillo. En Calicanto, una familia ha tenido que caminar estos d√≠as durante m√°s de una hora para llegar a un establecimiento que ten√≠a agua potable aunque a un precio astron√≥mico: \\\"Nos han cobrado 5 euros por cada botell√≠n de medio litro\\\", relata Manuel, el padre de una familia de cuatro miembros. No son los √∫nicos. Cristina, una vecina de Aldaia con un beb√© de pocos meses vivi√≥ una situaci√≥n similar en su municipio. \\\"Me quer√≠an cobrar 8 euros por un pack de agua\\\", se√±ala, al tiempo que agrega: \\\"Es una verg√ºenza y muy ruin por su parte. Ahora tendr√≠amos que estar todos arrimando el hombro\\\", defiende. Cristina, entr√≥ con su pareja y su beb√© a un peque√±o comercio de la ciudad y se llev√≥ el √∫ltimo paquete de agua que hab√≠a. \\\"Es vergonzoso que nos saquen el dinero en algo tan esencial como el agua. El due√±o nos vio entrar con un beb√© en brazos. Es de tener muy poca humanidad\\\", reivindica. Los casos se repiten por toda la provincia. En la mayor√≠a de las localidades afectadas por la DANA, los supermercados siguen arrasados o sin g√©nero, al no poder acceder los camiones de reparto. La encargada de un conocido supermercado explicaba ayer a este peri√≥dico que los camiones con productos frescos, como pescado y frutas y verduras, no hab√≠an podido llegar al establecimiento, pero s√≠ otros veh√≠culos cargados con agua potable. \\\"En cuanto llega, desaparece -se√±alaba-. Quiero pensar que es para donarla a los damnificados, pero me temo que mucha gente est√° haciendo acopio y en Val√®ncia ciudad y en los municipios que no han resultado afectados hay agua potable en el grifo: la embotellada la necesitan las personas que han sufrido la DANA\\\", insist√≠a A Cristina (como a la mayor√≠a) le ha salvado la solidaridad familiar y ciudadana. \\\"Por suerte mi prima ten√≠a algo de agua guardada y nos trajo una garrafa de 8 litros. Imag√≠nate la necesidad que cuando me la trajo la gente le preguntaba todo el rato por la calle que d√≥nde la hab√≠a comprado\\\", cuenta. En otras localidades como Picanya tambi√©n se est√°n pagando cantidades desorbitadas en algunos establecimientos. Rosa tiene dos hijos adolescentes y esta ma√±ana, a las 6.30 horas, ya estaban de camino a comprar \\\"a una panader√≠a que acaba de reabrir\\\". All√≠ han conseguido algo de agua y comida. \\\"Estamos todos los vecinos igual -explica-. Nos hemos podido ir arreglando con el supermercado pero el agua se ha llevado muchas cosas de nuestras casas y necesitamos lo m√°s urgente. Lo prioritario es el agua potable\\\". En Benet√∫sser, otra de las zonas arrasadas por la lluvia, algunos comercios han comenzado a vender agua embotellada a 5 euros. \\\"Mucha gente se fue sin comprar, pero hubo muchos que tuvieron que pasar por el aro porque no ten√≠an nada\\\", cuenta indignado un vecino. La situaci√≥n en muchas localidades es cr√≠tica, llegando a forzar las puertas de locales para sacar agua. En el pol√≠gono industrial de Benet√∫sser familias y personas mayores rebuscaban ayer en los supermercados saqueados en busca de agua potable. Incluso se lleg√≥ a acceder a locales de comida r√°pida para repartir entre las familias que pasaban las cajas de botellines de agua mientras los vecinos ped√≠an desesperadamente un punto de suministro desde el que las autoridades pudieran repartir v√≠veres. \\\"Todos los supermercados est√°n arrasados, y nuestras familias no pueden llegar en coche desde Valencia para traernos comida. Los v√≠veres de la nevera se han echado a perder porque no tenemos luz. No sabemos qu√© hacer\\\", protesta un padre de familia.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "spanish",
    "sentiment": "negative",
    "categories": [
      "Disaster and Accident",
      "Human Interest",
      "Weather"
    ],
    "ai_allow": true,
    "canonical": false,
    "webz_reporter": false,
    "external_links": [
      "https://estaticos-cdn.prensaiberica.es/clip/485a9b03-2ace-4561-b3d7-77ecda0133a9_source-aspect-ratio_default_0.webp",
      "https://estaticos-cdn.prensaiberica.es/clip/485a9b03-2ace-4561-b3d7-77ecda0133a9_source-aspect-ratio_640w_0.webp",
      "https://estaticos-cdn.prensaiberica.es/clip/485a9b03-2ace-4561-b3d7-77ecda0133a9_source-aspect-ratio_320w_0.webp",
      "https://www.estaticos-cdn.prensaiberica.es/clip/485a9b03-2ace-4561-b3d7-77ecda0133a9_source-aspect-ratio_320w_0.webp",
      "https://www.estaticos-cdn.prensaiberica.es/clip/485a9b03-2ace-4561-b3d7-77ecda0133a9_source-aspect-ratio_640w_0.webp",
      "https://www.estaticos-cdn.prensaiberica.es/clip/485a9b03-2ace-4561-b3d7-77ecda0133a9_source-aspect-ratio_default_0.webp"
    ],
    "external_images": [],
    "entities": {
      "persons": [
        {
          "name": "Gonzalo S√°nchez",
          "sentiment": "negative"
        },
        {
          "name": "Marga V√°zquez\nValencia",
          "sentiment": "neutral"
        }
      ],
      "organizations": [],
      "locations": [
        {
          "name": "Calicanto",
          "sentiment": "none"
        },
        {
          "name": "Picanya",
          "sentiment": "none"
        }
      ]
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "rating": null,
    "crawled": "2024-11-01T15:45:39.894+02:00",
    "updated": "2024-11-01T16:02:55.281+02:00"
  },
  {
    "uuid": "dc3ec34ccd532e5f1ba242f620caa4d135ffe833",
    "url": "https://www.abc.es/espana/principal-partido-oposicion-protesta-estambul-detencion-alcalde-20250409232105-vi.html",
    "ord_in_thread": 0,
    "author": "ABC.es",
    "published": "2025-04-09T21:21:00Z",
    "title": "El principal partido de la oposici√≥n protesta en Estambul contra la detenci√≥n de su alcalde",
    "text": "El principal partido de la oposici√≥n protesta en Estambul contra la detenci√≥n de su alcalde\nEstambul (Turqu√≠a), 9 abr (EFE/EPA).- El principal partido de la oposici√≥n, el Partido Republicano d...\nEstambul (Turqu√≠a), 9 abr (EFE/EPA).- El principal partido de la oposici√≥n, el Partido Republicano del Pueblo (CHP), ha organizado este mi√©rcoles una protesta en Estambul contra la detenci√≥n del alcalde de esta ciudad, Ekrem Imamoglu, tambi√©n del CHP. Imamoglu fue encarcelado y destituido por el Ministerio del Interior turco el pasado 23 de marzo por cargos de corrupci√≥n, tras su detenci√≥n el 19 de marzo junto con otras 100 personas. IM√ÅGENES: ERDEM SAHIN INCLUYE IM√ÅGENES DE RECURSO DE LA PROTESTA DE LA OPOSICI√ìN TURCA CONTRA LA DETENCI√ìN DEL ALCALDE DE ESTAMBUL, EKREM IMAMOGLU, EN ESTA CIUDAD HOM√ìNIMA, EN TURQU√çA.\nEsta funcionalidad es s√≥lo para suscriptores\nSuscribete",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "spanish",
    "sentiment": "negative",
    "categories": [
      "Politics",
      "Social Issue",
      "Crime, Law and Justice"
    ],
    "topics": [
      "Politics->political dissent",
      "Politics->civil rights",
      "Politics->political parties and movements",
      "Social Issue->social problem",
      "Social Issue->values",
      "Social Issue->discrimination",
      "Crime, Law and Justice->investigation (criminal)",
      "Crime, Law and Justice->corruption",
      "Crime, Law and Justice->law enforcement"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": true,
    "webz_reporter": false,
    "external_links": [],
    "entities": {
      "persons": [
        {
          "name": "EKREM IMAMOGLU",
          "sentiment": "none"
        }
      ],
      "locations": [],
      "organizations": [
        {
          "name": "Partido Republicano del Pueblo",
          "sentiment": "none",
          "tickers": []
        },
        {
          "name": "Ministerio del Interior",
          "sentiment": "none",
          "tickers": []
        },
        {
          "name": "EFE",
          "sentiment": "none",
          "tickers": []
        },
        {
          "name": "CHP",
          "sentiment": "none",
          "tickers": [
            {
              "ticker": "CHP",
              "exchange": "JSE"
            }
          ]
        }
      ]
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "bias": null,
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-04-10T00:35:58.314+03:00",
    "updated": "2025-04-10T00:35:58.314+03:00"
  },
  {
    "uuid": "d3b31ff9c92ce1b3a3262d6db15b7be25c140cb1",
    "url": "https://www.viveusa.mx/noticias/suman-136-los-muertos-tras-derrumbe-del-techo-de-discoteca-en-republica-dominicana",
    "ord_in_thread": 0,
    "author": "@Vive_USA",
    "published": "2025-04-09T21:32:00Z",
    "title": "Suman 136 los muertos tras derrumbe del techo de discoteca en Rep√∫blica Dominicana",
    "text": "La cifra de muertos tras el desplome la madrugada de ayer del techo de una discoteca en Santo Domingo se eleva a 136 y podr√≠a aumentar, seg√∫n datos ofrecidos por uno de los responsables del trabajo de los socorristas.\nEl oficial a cargo de las labores de rescate por parte del Cuerpo de Bomberos del Distrito Nacional, Jos√© Luis Herasme, inform√≥ que los socorristas han extra√≠do otros 12 cuerpos de unos 20 que han sido localizados bajo los escombros de la discoteca Jet Set.\nEl alto oficial ofreci√≥ los datos en presencia del director del Centro de Operaciones de Emergencias (COE), Juan Manuel M√©ndez, el portavoz de las operaciones, quien no confirm√≥ lo dicho por Herasme, pero tampoco lo desminti√≥ y adelant√≥ que, \"por respeto a los familiares de los fallecidos\", se ofrecer√°n detalles m√°s ampliados, este mismo martes",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "spanish",
    "sentiment": "negative",
    "categories": [
      "Disaster and Accident",
      "Social Issue",
      "Crime, Law and Justice"
    ],
    "topics": [
      "Disaster and Accident->structural failure",
      "Disaster and Accident->disaster",
      "Disaster and Accident->emergency response",
      "Social Issue->death and dying",
      "Social Issue->social condition",
      "Social Issue->social problem",
      "Crime, Law and Justice->homicide",
      "Crime, Law and Justice->investigation (criminal)"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": true,
    "webz_reporter": false,
    "external_links": [],
    "entities": {
      "persons": [
        {
          "name": "Juan Manuel M√©ndez",
          "sentiment": "none"
        },
        {
          "name": "Jos√© Luis Herasme",
          "sentiment": "none"
        }
      ],
      "locations": [
        {
          "name": "Santo Doming",
          "sentiment": "none"
        }
      ],
      "organizations": [
        {
          "name": "Cuerpo de Bomberos del Distrito Nacional",
          "sentiment": "none",
          "tickers": []
        },
        {
          "name": "COE",
          "sentiment": "none",
          "tickers": []
        }
      ]
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "bias": null,
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-04-10T00:58:44.693+03:00",
    "updated": "2025-04-10T00:58:44.693+03:00"
  },
  {
    "uuid": "53679b3ba32380edd8b8bdf0f19cba7443c28daa",
    "url": "https://www.eldebate.com/internacional/20240926/erdogan-compara-netanyahu-hitler-asegura-acabara-como-dictador_230884.html",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "El Debate",
    "published": "2024-09-26T18:53:00Z",
    "title": "Erdogan compara a Netanyahu con Hitler y asegura que acabar√° como el dictador",
    "text": "Erdogan compara a Netanyahu con Hitler y asegura que acabar√° como el dictador El presidente turco declar√≥ que ¬´Hitler tambi√©n tuvo un sue√±o e hizo vivir una pesadilla a personas de varias naciones¬ª Actualizada 19:53 El presidente turco, el islamista Recep Tayyip Erdogan, afirm√≥ este jueves que Israel, que est√° bombardeando posiciones del grupo paramilitar de Hezbol√° en el L√≠bano, tiene un ¬´sue√±o como lo tuvo Hitler¬ª, por lo que tendr√° el ¬´mismo final¬ª que el l√≠der nazi. Al responder a preguntas de periodistas turcos en su avi√≥n de regreso de la Asamblea General de la ONU de Nueva York a Turqu√≠a, el mandatario turco compar√≥ una vez m√°s al primer ministro israel√≠, [Benjam√≠n Netanyahu](https://www.eldebate.com/internacional/20240918/asamblea-general-onu-pide-fin-ocupacion-israeli-territorios-palestinos_228545.html), con Adolf Hitler. ¬´Israel est√° so√±ando y parece dispuesto a convertir las vidas de la gente de nuestra regi√≥n en pesadillas para realizar ese sue√±o¬ª, dijo el presidente turco, quien acus√≥ al Gobierno israel√≠ de querer extender la guerra por toda la regi√≥n. Para concluir: ¬´Al final, se dio cuenta claramente de que lo que ve√≠a no era m√°s que un sue√±o. Tarde o temprano, Netanyahu, el Hitler de hoy, tambi√©n se enfrentar√° a esta realidad. Todo el mundo tiene un plan, pero nosotros creemos que Dios tambi√©n tiene un plan¬ª, sentenci√≥. Reuni√≥n ministros AA.EE. [La Uni√≥n Europea invita, por primera vez, a Turqu√≠a a la reuni√≥n de ministros de Exteriores](/internacional/20240829/union-europea-invita-primera-vez-turquia-reunion-ministros-exteriores_223345.html) Hezbol√° es una organizaci√≥n chi√≠, apoyada, armada y financiada por Ir√°n. Este grupo est√° considerado como terrorista por numerosos pa√≠ses occidentales, entre ellos Estados Unidos y la Uni√≥n Europea. Tras la ofensiva israel√≠ contra Gaza, que sigui√≥ a los atentados del grupo integrista palestino Ham√°s contra el sur de Israel el 7 de octubre 2023, Hezbol√° comenz√≥ a atacar al pa√≠s vecino a diario con sus cohetes. Erdogan tambi√©n protest√≥ hoy por la presencia de Netanyahu en la Asamblea General de la ONU mientras que es investigado por la Corte Internacional de Justicia por supuestos cr√≠menes de guerra. ¬´El hecho de que un criminal que ha cometido genocidio en Palestina pueda estar bajo el techo de las Naciones Unidas es verdaderamente una verg√ºenza. Es una traici√≥n a la memoria de los beb√©s, ni√±os, madres, padres, funcionarios de la ONU, periodistas y muchos otros brutalmente asesinados¬ª, concluy√≥ Erdogan.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "spanish",
    "sentiment": "negative",
    "categories": [
      "Politics",
      "War, Conflict and Unrest",
      "Social Issue"
    ],
    "ai_allow": true,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "rating": null,
    "crawled": "2024-09-27T02:15:43.969+03:00",
    "updated": "2024-09-27T02:15:43.969+03:00"
  }
]